Table 1 Characteristics of morbidly obese men and women
From: Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional study
Total (n=2026) | Men (n=690) | Women (n=1336) | Pa | |
|---|---|---|---|---|
Age (years) | 43.1 (12.2)b | 45.0 (12.1) | 42.2 (12.2) | <0.001 |
Caucasian | 1960 (97%)c | 672 (98%) | 1288 (97%) | 0.660 |
Current smoker | 535 (26%) | 140 (20%) | 395 (30%) | <0.001 |
Vitamin D supplement | 231 (11%) | 65 (9%) | 166 (12%) | 0.046 |
Winter season (November through till February) | 762 (38%) | 267 (39%) | 495 (37%) | 0.468 |
Anthropometric measures | ||||
Weight (kg) | 131 (22) | 145 (22) | 124 (18) | <0.001 |
Height (cm) | 172 (9) | 180 (7) | 167 (7) | <0.001 |
BMI (kg/m2) | 44.4 (5.9) | 44.6 (6.0) | 44.3 (5.9) | 0.302 |
Waist (cm) | 131 (14) | 140 (13) | 127 (13) | <0.001 |
Hip (cm) | 133 (12) | 130 (12) | 135 (12) | <0.001 |
Waist-to-hip ratio | 0.99 (0.1) | 1.08 (0.08) | 0.94 (0.08) | <0.001 |
Physically actived | 458 (32%) | 165 (32%) | 293 (31%) | 0.723 |
Co-morbidity | ||||
Type 2 diabetes | 499 (25%) | 233 (34%) | 266 (20%) | <0.001 |
Coronary artery disease | 91 (5%) | 69 (10%) | 22 (2%) | <0.001 |
Biomarkers | ||||
25-hydroxyvitamin D (nmol/l) | 52.4 (22.3) | 50.0 (22.0) | 53.6 (22.4) | 0.001 |
Vitamin D deficiency | 1019 (50%) | 386 (56%) | 633 (47%) | <0.001 |
PTH (pmol/l) | 6.7 (3.8) | 7.1 (4.8) | 6.5 (3.2) | 0.003 |
Secondary hyperparathyroidism | 691 (34%) | 255 (37%) | 436 (33%) | 0.054 |
Insulin, fasting (pmol/l) | 127.1 (112.6) | 144.0 (99.6) | 118.4 (117.9) | <0.001 |
CRP (pg/ml) | 10.7 (11) | 9.3 (12.9) | 11.5 (9.8) | <0.001 |
CRP⩾7 (pg/ml) | 1308 (65%) | 378 (55%) | 930 (70%) | <0.001 |
